Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

被引：0
|
作者：
Perez-Lopez, Olga [1 ,2 ]
Caballero-Velazquez, Teresa [1 ,2 ]
Colado, Enrique [3 ]
Alonso, Sara [3 ]
Gonzalez-Campos, Jose [1 ,2 ]
Prats-Martin, Concepcion [1 ,2 ]
Rodriguez-Torres, Nancy [1 ,2 ]
Escamilla Gomez, Virginia [1 ,2 ]
Espigado, Ildefonso [1 ]
Antonio Perez-Simon, Jose [1 ,2 ]
机构：
[1] Hosp Univ Virgen del Rocio, Dept Hematol, Seville, Spain
[2] Univ Seville, Inst Biomed Sevilla IBIS, CSIC, Seville, Spain
[3] Hosp Univ Cent Asturias, Dept Hematol, Oviedo, Spain
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119437
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5733
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia
    Rebecca Levin-Epstein
    Caspian Oliai
    Gary Schiller
    Current Treatment Options in Oncology, 2018, 19
  • [32] Value of pre-transplantation minimal residual disease in acute myelioid leukemia and myeloablative allogeneic hematopoietic cell transplantation
    Kwon, M.
    Franco Villegas, A. C.
    Balsalobre, P.
    Buno, I.
    Martinez-Laperche, C.
    Anguita, J.
    Perez Corral, A.
    Pascual, C.
    Serrano, D.
    Gayoso, J.
    Diez, J. L.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S261 - S261
  • [33] Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukaemia before and after allogeneic haemopoietic stem cell transplantation
    Bastos Oreiro, M.
    Perez Corral, A.
    Pascual Izquierdo, C.
    Martinez Laperche, C.
    Kwon, M.
    Gayoso, J.
    Buno, I.
    Serrano, D.
    Anguita, J.
    Diez-Martin, J. L.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S397 - S398
  • [34] Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
    Gang, Margery
    Othus, Megan
    Walter, Roland B.
    CELLS, 2025, 14 (04)
  • [35] Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning for Mixed Phenotype Acute Leukemia with Minimal Residual Disease
    Manabe, Shuji
    Nakamura, Sayaka
    Toujyo, Ryunosuke
    Saito, Atsuro
    Kozaki, Aiko
    Ishida, Toshiaki
    Kishimoto, Kenji
    Mori, Takeshi
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [36] INTERFERON-A IS EFFECTIVE FOR TREATMENT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Mo, X. -D.
    Zhang, X. -H.
    Xu, L. -P.
    Wang, Y.
    Yan, C. -H.
    Chen, H.
    Chen, Y. -H.
    Han, W.
    Wang, F. -R.
    Wang, J. -Z.
    Liu, K. -Y.
    Huang, X. -J.
    HAEMATOLOGICA, 2017, 102 : 133 - 134
  • [37] History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease-negative first complete remission
    Rashidi, Armin
    Linden, Michael A.
    DeFor, Todd E.
    Warlick, Erica
    Bejanyan, Nelli
    Yohe, Sophia
    Weisdorf, Daniel J.
    Ustun, Celalettin
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : 1032 - 1036
  • [38] Real World Utility of Treating Minimal Residual Disease after Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
    Krakow, Elizabeth F.
    Baker, Kelsey K.
    Gooley, Ted A.
    Nathe, Julia M.
    Perez, Tess M.
    Flowers, Mary E.
    Mielcarek, Marco
    Sandmaier, Brenda M.
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 547 - 547
  • [39] The impact of minimal residual disease and its kinetics prior to different types of allogeneic hematopoietic stem cell transplantation on clinical outcomes in patients with acute myeloid leukemia
    Xiao-su, Z.
    Yan-rong, L.
    Yan-Hong
    Xu-ying, P.
    Qian-Jiang
    Hao-Jiang
    Xu, Lan-ping
    Zhang, Xiao-hui
    Yu-Wang
    Xiao-jun, H.
    Ying-jun, C.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S510 - S511
  • [40] Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia
    Sramkova, Lucie
    Muzikova, Katerina
    Fronkova, Eva
    Krejci, Ondrej
    Sedlacek, Petr
    Formankova, Renata
    Mejstrikova, Ester
    Stary, Jan
    Trka, Jan
    PEDIATRIC BLOOD & CANCER, 2007, 48 (01) : 93 - 100
12345